Tyler Bussian
Stock Analyst at Brookline Capital
(0)
# 5030
Out of 5,243 analysts
5
Total ratings
0.00%
Success rate
-39.64%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Envoy Medical | Initiates Coverage On: Buy | 9 | 1.54 | 484.42% | 1 | Oct 14, 2024 | |
CervoMed | Initiates Coverage On: Buy | 63 | 2.2 | 2763.64% | 1 | Jul 8, 2024 | |
Immunic | Initiates Coverage On: Buy | 10 | 0.95 | 952.63% | 1 | Apr 5, 2024 | |
Annovis Bio | Downgrades: Hold | 9 | 5.23 | 72.08% | 2 | Feb 28, 2024 |